• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Targeted Radionuclide Therapy

Targeted Radionuclide Therapy

9780781796934
800.10 zł
720.09 zł Save 80.01 zł Tax included
Lowest price within 30 days before promotion: 720.09 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description

Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion.

A companion website includes the full text and an image bank.

Product Details
48126
9780781796934
9780781796934

Data sheet

Publication date
2010
Issue number
1
Cover
hard cover
Pages count
608
Dimensions (mm)
213 x 276
Weight (g)
1565
  • Part I:: IMMUNOLOGY AND TARGETING CONSTRUCTS

    1:: The Immune System

    2:: Methods for Development of Monoclonal Antibody Therapeutics

    3:: Peptides

    4:: Affibody Molecules for Targeted Radionuclide Therapy

    5:: Aptamers

    Part II:: PHYSICS AND RADIOBIOLOGY OF TRT

    6:: The Physics and Radiobiology of TRT

    7:: Chelation Chemistry

    8:: Radiation Dosimetry

    9:: Microdosimetry

    10:: Radiation Safety for RT

    Part III:: TUMOR MICROENVIRONMENT AND DELIVERY STRATEGIES

    11:: Employing SEREX

    12:: Antibody Penetration into Tumors

    13:: Overcoming Barriers Posed by Solid Tumors

    14:: The Delivery Construct

    15:: The Type of Radionuclide

    16:: Pretargeting Strategies for TRT

    17:: Combined Modality Strategies

    18:: Extracorporeal Techniques

    19:: Concept of Systemic Therapy

    20:: Modeling of the Systemic Cure with TRT

    Part IV:: UNCONJUGATED THERAPY

    21:: Thyroid Cancer

    22:: Unconjugated Radiopharmaceuticals

    23:: 90-y Microspheres

    24:: SIRT

    Part V:: CONJUGATED THERAPY

    25:: Colorectal Cancer

    26:: Pancreatic Cancer

    27:: Hepatobillary Cancer

    28:: Astrocytoma

    29:: Medullary Thyroid Cancer

    30:: Head and Neck Cancer

    31:: Prostate Cancer

    32:: Renal Cell Carcinoma

    33:: Bladder Cancer

    34:: Leukemia

    35:: Non-Hodgkins Lymphoma

    36:: Hodgkins Disease

    37:: Multiple Myeloma

    38:: Neuroendocrine Tumors

    39:: Malignancies Treated with Peptides

    40:: Ovarian Cancer

    41:: Osteosarcoma

    42:: Pediatric Tumors

    43:: Palliation

    44:: Melanoma

Comments (0)